Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
31 articles · 1 journals
Journals in this subcategory (1)
- Value in Health Regional Issues · Elsevier (31)
- Comparative Costs and Diagnostic Yields of Next-Generation Sequencing Versus Muscle Biopsy for Multiplex Ligation-Dependent Probe Amplification-Negative Duchenne Muscular Dystrophy
- Strengthening Stakeholder Participation in Ukraine’s Health Technology Assessment Process: Evidence from a Cross-Country Comparison
- Comparative Analysis of Medical Device Regulatory Frameworks Across Countries
- Quantifying the Economic Impact of Residential Fire-Related Fatalities in New South Wales, Australia
- Valuing Health States: An EQ-5D-5L Value Set for Uzbekistan
- Defining the Cost-Effectiveness Threshold Locally: What Is the Most Appropriate Number for my Jurisdiction?
- Pricing, Availability, and Affordability of Cancer Medicines in 5 Upper-Middle-Income South American Countries
- Empirical Estimation of the Discount Rate for Pharmacoeconomic Evaluation in China
- Economic Impact of a Structured Early Breast Cancer Detection Initiative in the Brazilian Private Health Sector
- Cost-Effectiveness Analysis of Newborn Screening for Spinal Muscular Atrophy in Argentina
- Cost-Minimization and Budget-Impact Analysis of N-Terminal Pro B-Type Natriuretic Peptide Biomarker Assay for the Risk Assessment and Monitoring of Pulmonary Arterial Hypertension in the Australian Healthcare Setting
- Toward Cost-Effectiveness Analyses in Municipal Long-Term Care Services: Mapping the Norwegian Register-Based Disability Measure to EQ-5D-3L
- Equity-Informative Real-World Evidence: Regional Lessons From Asia and the United Kingdom
- Routine Distributional Analysis of Health Inequality Impact by Socioeconomic Group: Technical Feasibility Study in Queensland, Australia
- Probabilistic Sensitivity Analysis of Thalassemia Screening Cascade Efficiency: Single-Sample Versus Multivisit Protocols in Malaysia
- Cost-Effectiveness Analysis of Asciminib in Patients With Chronic Phase Chronic Myeloid Leukemia Previously Treated With 2 or More Tyrosine Kinase Inhibitors in Colombia
- Cost-Effectiveness Analysis of Fecal Immunochemical Test-based Versus Total Colonoscopy-Based Colorectal Cancer Screening in Japan: A Microsimulation Study
- Cost-Utility Analysis of Sentinel Node Biopsy Versus Selective Neck Dissection for Node-Negative Early-Stage Oral Cancers: A Health Economic Evaluation from the Indian Healthcare System Perspective
- Cost-Effectiveness Analysis of Carfilzomib vs Bortezomib in Relapsed/Refractory Multiple Myeloma in Iran
- How Evidence Transforms the Funding of Lower-Extremity Arthroplasty Implants in Chile: Costs and Clinical Variability Under the Diagnosis Related Groups System
- Budget Impact Analysis of System-Level Costs Associated With Topical Janus Kinase Inhibitor Therapies for Moderate Atopic Dermatitis in Germany
- Cost-Effectiveness of Peripheral Neuropathy Screening in Patients With Thalassemia: A Hybrid Decision-Markov Model
- Brazilian Expert Consensus on the Use of Equity and Acceptability in Health Technology Assessment: A Delphi Panel
- Disparity Considerations in an Alternative Eligibility Criterion for Medicare Medication Therapy Management Programs With Machine Learning
- Behavioral Economics as a Driver of Healthcare System Reform: Methodological Approach
- Mapping Minnesota Living with Heart Failure Questionnaire Onto EQ-5D-5L and SF-6Dv2 in Iranian Patients With Ischemic Heart Failure
- Development and Psychometric Validation of the TF-Col: A Patient- and Caregiver-Reported Measure of Financial Toxicity in Oncology
- Development and Real-World Application of a Consumption-Based Model for Projecting the Budget Impact of High-Cost Reserve Antibiotics in a University Hospital
- Partial Economic Evaluation and Clinical Impact of a Stewardship Quality-Improvement Intervention to Reduce Intravenous Antibiotic Duration: A Quasi-Experimental Study
- Budget Impact Analysis and Alternative Funding Solutions of Sacubitril/Valsartan for the Treatment of Heart Failure With Reduced Ejection Fraction in Thailand